A Comparison of the In Vitro Effects of 2’Fucosyllactose and Lactose on the Composition and Activity of Gut Microbiota from Infants and Toddlers

Download Graphical Abstract
 

Summary:

This study, funded and co-authored by Nestlé Research, used two in vitro models – 48-hour fecal incubations, and the long-term mucosal simulator of the human intestinal microbial ecosystem (M-SHIMEÒ) – with fecal samples from 3-month-old breastfed (BF) infants or toddlers aged 2-3 years.

2’-FL fermentation was shown to strongly and immediately increase the relative abundance of Bifidobacteriaceae in the gut microbiota of both babies and toddlers. By contrast, lactose fermentation had a less immediate bifidogenic effect of the toddler microbiota, and did not increase the prevalence of Bifidobacteriaceae in the infant microbiota during the first two treatment weeks. 2’-FL fermentation was also associated with consistently lower gas production than fermentation of lactose. This suggests that 2’-FL not only promotes the growth of beneficial bifidobacteria, but may also help reduce intestinal discomfort. The study’s authors further theorise that 2’-FL may plausibly help to maintain the presence and activity of bifidobacteria in the infant’s gut beyond six months of age, when weaning begins to diversify their microbiota.